Controlled studies in pregnant women show no evidence of fetal risk. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk. Animal studies show risk and human studies not available or neither animal nor human studies done. Contact the applicable plan provider for the most current information. D: Use in LIFE-THREATENING emergencies when no safer drug available. Plaquenil bronchospasm Hydroxychloroquine american academy of ophthalmology Chloroquine lysosomal membrane permeabilization Influence of route of administration on the pharmacokinetics of chloroquine and desethylchloroquine Article PDF Available in Bulletin of the World Health Organisation 65147-50 February. Hydroxychloroquine HCQ, sold under the brand name Plaquenil among others, is a medication used for the prevention and treatment of certain types of malaria. Specifically it is used for chloroquine-sensitive malaria. Other uses include treatment of rheumatoid arthritis, lupus, and porphyria cutanea tarda. It is taken by mouth. It is also being used as an experimental treatment for SARS-CoV-2. Dosage Form/Route Marketing Status TE Code RLD RS; CHLOROQUINE PHOSPHATE CHLOROQUINE PHOSPHATE. CHLOROQUINE PHOSPHATE CHLOROQUINE PHOSPHATE EQ 300MG BASE. U. S. Food and Drug Administration 10903 New Hampshire Avenue Silver Spring, MD 20993 1-888-INFO-FDA 1-888-463-6332 Active against erythrocytic forms of Plasmodium vivax & P. malariae and most strains of Plasmodium falciparum Precise mechanism not known Bioavailability: ~89% Peak plasma time: 1-2 hr Distributed widely in body tissues (eg, eyes, heart, kidneys, liver, lungs) where retention prolonged; crosses placenta; enters breast milk Partially in liver Half-life: 3-5 days Excretion: urine (~70% as unchanged drug); acidification of urine increases elimination Small amounts may be present in urine months following discontinuation of therapy The above information is provided for general informational and educational purposes only. Chloroquine route of administration WHO Model Prescribing Information Drugs Used in Parasitic., Hydroxychloroquine - Wikipedia Chloroquine cornea ARALEN, chloroquine phosphate, USP, is a 4-aminoquinoline compound for oral administration. It is a white, odorless, bitter tasting, crystalline substance, freely soluble in water. ARALEN is an antimalarial and amebicidal drug. Aralen Chloroquine Uses, Dosage, Side Effects.. [email protected] FDA-Approved Drugs - Food and Drug Administration. Chloroquine C18H26ClN3 - PubChem. Route of Administration shall consist of an alphabetic term which has a maximum length shall be restricted to 60 characters, with the hyphen and virgule being only punctuation permissible. Individuals often report with greater depth of itching each time they use the sulphate preparation. Some people often report itching to the tablets without itching to the injectable formulation. This means chloroquine that the intensity of chloroquine itching could also be lowered by altering the route and type of administration as earlier advised. Chloroquine phosphate tablets, Chloroquine phosphate, USP, is a 4-aminoquinoline compound for oral administration. It is a white, odorless, bitter tasting, crystalline substance, freely soluble inwater.